Ependymoma: Evaluation and Management Updates.
Roberta RudàFrancesco BrunoAlessia PellerinoRiccardo SoffiettiPublished in: Current oncology reports (2022)
Ependymomas may occur either in the brain or in the spinal cord. Compared with intracranial ependymomas, spinal ependymomas are less frequent and exhibit a better prognosis. The new WHO classification of CNS tumors of 2021 has subdivided ependymomas into different histomolecular subgroups with different outcome. The majority of studies have shown a major impact of extent of resection; thus, a complete resection must be performed, whenever possible, at first surgery or at reoperation. Conformal radiotherapy is recommended for grade 3 or incompletely resected grade II tumors. Proton therapy is increasingly employed especially in children to reduce the risk of neurocognitive and endocrine sequelae. Craniospinal irradiation is reserved for metastatic disease. Chemotherapy is not useful as primary treatment and is commonly employed as salvage treatment for patients failing surgery and radiotherapy. Standard treatments are still the mainstay of treatment: the discovery of new druggable pathways will hopefully increase the therapeutic armamentarium in the near future.
Keyphrases
- spinal cord
- end stage renal disease
- minimally invasive
- squamous cell carcinoma
- early stage
- locally advanced
- chronic kidney disease
- machine learning
- small molecule
- lymph node
- radiation induced
- peritoneal dialysis
- prognostic factors
- coronary artery disease
- acute coronary syndrome
- atrial fibrillation
- high throughput
- brain injury
- neuropathic pain
- replacement therapy
- optical coherence tomography
- percutaneous coronary intervention
- resting state
- cerebral ischemia